FDA Approves Orexigen's Weight-Loss Drug

The Wall Street Journal (online registration required): The U.S. Food and Drug Administration said it approved Orexigen Therapeutics Inc.'s weight-loss treatment Contrave, the third such drug to receive the agency's approval in recent years.

Contrave has been approved as a treatment for chronic weight management in addition to a reduced-calorie diet and physical activity, the FDA said Wednesday in a...

Read article

i360Gov Newsletters

The most significant government policy, business, and technology news and analysis delivered to your inbox.

Subscribe Now

Trending